Trading Signals: TGTX Stock Price Prediction and Forecast (Mon. Aug. 10, 2015 - Wed. Sep. 14, 2022)(TG Therapeutics Inc)
| TGTX latest price $36.5700 (-2.95%) ($36.5700 - $36.5700) on Wed. May. 12, 2021. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 3.47% (three month average) | RSI | 40 | Latest Price | $36.5700(-2.95%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | TGTX declines -2.5% a day on average for past five trading days. | Weekly Trend | TGTX declines -5.7% a week on average for past two weeks. | Market Behavior | Broad based sell-off for large cap. Broad based sell-off for small cap. | Correlated ETFs | Broad market will support TGTX advance at 0% a week (0% probability) XBI(68%) ARKG(63%) ARKK(59%) IWO(59%) IBB(58%) | Factors Impacting TGTX price | TGTX will decline at least -1.735% in a week (0% probabilities). VIXM(-42%) VXX(-36%) UUP(-18%) UNG(-3%) TLT(-2%) | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -1.735% (StdDev 3.47%) | Hourly BBV | -1.8 () | Intraday Trend | 0% | | | |
|
1 - 5 Day Possible Target | $27.98(-23.49%) | Resistance Level | $41.62 | 5 Day Moving Average | $38.41(-4.79%) | 10 Day Moving Average | $40.4(-9.48%) | 20 Day Moving Average | $41.62(-12.13%) | To recent high | -27.4% | To recent low | 0% | Market Cap | $4.632b | | | | TG Therapeutics, Inc. is a biopharmaceutical company, which engages in the acquisition, development, and commercialization of novel treatments for B-cell malignancies and autoimmune diseases. Its product pipeline includes TG-1101, Ublituximab, and Umbralisib. The company was founded by Michael Sean Weiss and Laurence H. Shaw on May 18, 1993 and is headquartered in New York, NY. |